86 related articles for article (PubMed ID: 7527957)
1. FK 506 rescue therapy for irreversible airway rejection in heart-lung transplant recipients: report on five cases.
Knoop C; Antoine M; Vachiéry JL; Yernault JC; Estenne M
Transplant Proc; 1994 Dec; 26(6):3240-1. PubMed ID: 7527957
[No Abstract] [Full Text] [Related]
2. FK 506 rescue therapy for hepatic allograft rejection: experience with an aggressive approach.
Woodle ES; Perdrizet GA; So SK; White HM; Marsh JW
Clin Transplant; 1995 Feb; 9(1):45-52. PubMed ID: 7537988
[TBL] [Abstract][Full Text] [Related]
3. Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience.
Alloway RR; Russell WC; Gaber LW; Amiri MH; Vera SR; Gaber AO
Transplant Proc; 1996 Apr; 28(2):995-7. PubMed ID: 8623494
[No Abstract] [Full Text] [Related]
4. FK 506 used as rescue therapy for refractory liver allograft rejection.
Chen CL; Eng HL; Chen YS; Kuo YC; Sun CK
Transplant Proc; 1994 Aug; 26(4):1927-9. PubMed ID: 7520612
[No Abstract] [Full Text] [Related]
5. How successful is OKT3 rescue therapy for steroid-resistant acute rejection episodes after heart transplantation?
Wagner FM; Reichenspurner H; Uberfuhr P; Kur F; Kaulbach HG; Meiser BM; Ziegler U; Reichart B
J Heart Lung Transplant; 1994; 13(3):438-42; discussion 442-3. PubMed ID: 8061020
[TBL] [Abstract][Full Text] [Related]
6. OKT3 vs FK 506 rescue management of acute steroid-resistant and chronic rejection.
Platz KP; Mueller AR; Zytowski M; Bechstein WO; Blumhardt G; Lobeck H; Neuhaus P
Transplant Proc; 1995 Feb; 27(1):1111-3. PubMed ID: 7533357
[No Abstract] [Full Text] [Related]
7. High-dose cyclosporine A induction therapy in liver transplant recipients with normal postoperative renal function: a prospective study.
Cherqui D; Duvoux C; Salvat A; Lauzet JY; Metreau JM; Julien M; Fagniez PL; Dhumeaux D
Transplant Proc; 1995 Feb; 27(1):1134-5. PubMed ID: 7878824
[No Abstract] [Full Text] [Related]
8. Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506.
Woodle ES; Thistlethwaite JR; Haas M; Josephson MA; Newell KA; Bruce DS; Millis JM; Piper JB; Charette JI
Transplant Proc; 1996 Apr; 28(2):998-9. PubMed ID: 8623495
[No Abstract] [Full Text] [Related]
9. Pulmonary rejection diagnosis after lung and heart-lung transplantation.
Reichenspurner H; Dienemann H; Rihl M; Wagner F; Meiser BM; Kur F; Hammer C; Forst H; Kreuzer E; Reichart B
Transplant Proc; 1993 Dec; 25(6):3299-300. PubMed ID: 8266550
[No Abstract] [Full Text] [Related]
10. Treatment of acute renal transplant rejection with FK 506 in patients on cyclosporine after failure of standard antirejection therapy.
Scott-Douglas N; Zimmerman D; Klassen J
Transplant Proc; 1996 Dec; 28(6):3165. PubMed ID: 8962226
[No Abstract] [Full Text] [Related]
11. Initial experience with tacrolimus rescue therapy in OKT3 resistant rejection.
Herget S; Heemann U; Friedrich J; Kribben A; Wagner K; Philipp T
Clin Nephrol; 1996 May; 45(5):352-4. PubMed ID: 8738671
[TBL] [Abstract][Full Text] [Related]
12. FK 506 rescue therapy: the rapidity of rejection reversal is related to the subsequent development of CMV disease.
Woodle ES; Perdrizet GA; So S; Jendrisak MD; White HM; Marsh JW
Transplant Proc; 1993 Apr; 25(2):1992-3. PubMed ID: 7682360
[No Abstract] [Full Text] [Related]
13. FK 506 in the treatment of steroid- and OKT3-resistant rejection in renal transplant recipients: reduced dosage and anti-infective prophylaxis.
Kliem V; Eberhard OK; Oldhafer K; Schlitt HJ; Behrend M; Schaumann D; Pichlmayr R; Koch KM; Brunkhorst R
Transplant Proc; 1996 Dec; 28(6):3166-8. PubMed ID: 8962227
[No Abstract] [Full Text] [Related]
14. Efficacy of tacrolimus in the treatment of refractory rejection in heart and lung transplant recipients.
Onsager DR; Canver CC; Jahania MS; Welter D; Michalski M; Hoffman AM; Mentzer RM; Love RB
J Heart Lung Transplant; 1999 May; 18(5):448-55. PubMed ID: 10363689
[TBL] [Abstract][Full Text] [Related]
15. Use of Prograf (FK 506) as rescue therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.
Klintmalm GB; Goldstein R; Gonwa T; Wiesner RH; Krom RA; Shaw BW; Stratta R; Ascher NL; Roberts JW; Lake J
Transplant Proc; 1993 Feb; 25(1 Pt 1):679-88. PubMed ID: 7679840
[TBL] [Abstract][Full Text] [Related]
16. Conversion of renal transplant immunosuppression from tacrolimus (FK 506) to cyclosporine: a single center experience.
Ichikura H; Tanabe K; Tokumoto T; Shimuzu T; Ishikawa N; Harano M; Inui M; Manu M; Ito S; Shimmura H; Okuda H; Yagisawa T; Fuchinoue S; Toma H
Transplant Proc; 2000 Nov; 32(7):1733-5. PubMed ID: 11119911
[No Abstract] [Full Text] [Related]
17. Tacrolimus (FK 506) in clinical cardiac transplantation: a five-year experience.
Pham SM; Kormos RL; Kawai A; Murali S; Hattler BG; Demetris AJ; Griffith BP
Transplant Proc; 1996 Apr; 28(2):1002-4. PubMed ID: 8623208
[No Abstract] [Full Text] [Related]
18. Use of FK 506 for the prevention of recurrent allograft rejection after successful conversion from cyclosporine for refractory rejection. US Multicenter FK 506 Liver Study Group.
Klintmalm GB; Goldstein R; Gonwa T; Wiesner RH; Krom RA; Shaw BW; Stratta R; Ascher NL; Roberts JW; Lake J
Transplant Proc; 1993 Feb; 25(1 Pt 1):635-7. PubMed ID: 7679826
[No Abstract] [Full Text] [Related]
19. FK 506 rescue therapy in liver transplant recipients with drug-resistant rejection.
Lewis WD; Jenkins RL; Burke PA; Winn KM; Shaffer D; Lopez R; Monaco AP
Transplant Proc; 1991 Dec; 23(6):2989-91. PubMed ID: 1721336
[No Abstract] [Full Text] [Related]
20. Tacrolimus (FK506) proves superior to OKT3 for treating episodes of persistent rejection following intrathoracic transplantation.
Meiser BM; Uberfuhr P; Schulze C; Fuchs A; Mair H; Reichenspurner H; Kreuzer E; Reichart B
Transplant Proc; 1997; 29(1-2):605-6. PubMed ID: 9123150
[No Abstract] [Full Text] [Related]
[Next] [New Search]
